BSEBoard Meeting18h ago · 2 Oct 2026, 06:57 pm

Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/10/2026 ,inter alia, to consider and approve To consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, Firm Registration No. 000816S, as the Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of M/s. Vasavi & Co., Chartered Accountants, subject to the recommendation of ....

Transgene Biotek Ltd · 526139

✦ AI SummaryAuditor Change

Transgene Biotek Ltd has scheduled a board meeting on October 10, 2026, to consider the appointment of new statutory auditors, Eswara Rao & Co., and to consider other matters.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Transgene Biotek Ltd - 526139 - Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

0e5cb271-02f5-4e1b-9d92-0b0d7c117a28.pdf

pdf

Download →
View document text
Date 02-10-2026 The General Manager Department of Corporate Services – CRD BSE LIMITED, Phiroze Jeejeebhoy Towers Dalal Street, Mumbai 400 001. Dear Sir/Madam, Sub: Intimation of Board Meeting pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ref:- Scrip Code BSE: 526139. This is to inform you that a meeting of the Board of Directors of Transgene Biotek Limited is scheduled to be held on Saturday, October 10, 2026 at 11:00 A.M., inter alia, to consider and approve the following matters: 1) To consider and approve the appointment of M/s. Eswara Rao & Co., Chartered Accountants, Firm Registration No. 000816S, as the Statutory Auditors of the Company to fill the casual vacancy caused by the resignation of M/s. Vasavi & Co., Chartered Accountants, subject to the recommendation of the Audit Committee and approval of the members of the Company at a general meeting, in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.. 2) To consider and approve such other matters as may be decided by the Board. The Company has received the consent letter, eligibility certificate and other applicable confirmations from the proposed Statutory Auditors, M/s. Eswara Rao & Co., Chartered Accountants, represented by Ms. Karra Pranavi, Partner, Membership No. 232994, for consideration of their appointment. This intimation is being submitted to the Stock Exchange in compliance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the above information on record. Thanking you Yours Sincerely For TRANSGENE BIOTEK LIMITED DR K KOTESWARA RAO MANAGING DIRECTOR DIN: 02287235 Plot 69& 70 IDA Bollaram, Sangareddy District – 502 325, Telangana, India Ph: +91-40-65589499 Fax: +91-8458-279755 Web: www.transgenebiotek.com Email: info@transgenebiotek.com, CIN No: L85195AP1990PLC011065